Anybody have any thoughts on these articles from J
Post# of 85559
The US Food and Drug Administration approved the first cannabis-derived drug this week, but it can’t be sold until the Drug Enforcement Administration changes how it classifies the specific compound used . So what’s next?
It is likely that the DEA will reclassify CBD in the next 90 days
https://www.cnbc.com/2018/06/26/fdas-approval...e-ceo.html
https://www.theverge.com/2018/6/29/17518424/e...law-health